The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Hospira Inc

NYSE: HSP
Last

(U.S.) $89.95

Today's change-0.01 -0.01%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.
 

Hospira Inc

NYSE: HSP
Last

(U.S.) $89.95

Today's change-0.01 -0.01%
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

Hospira Inc down slightly

Hospira Inc closed down just (U.S.)$0.01 Wednesday to (U.S.)$89.95. Over the last five days, shares are unchanged, but have gained 46.86% over the last year to date. This security has outperformed the S&P 500 by 68.57% during the last year.

Key company metrics

  • Open(U.S.) $89.96
  • Previous close(U.S.) $89.96
  • High(U.S.) $89.98
  • Low(U.S.) $89.95
  • Bid / Ask(U.S.) $89.95 / (U.S.) $89.97
  • YTD % change+46.86%
  • Volume13,146,843
  • Average volume (10-day)4,064,112
  • Average volume (1-month)2,215,086
  • Average volume (3-month)1,448,384
  • 52-week range(U.S.) $46.56 to (U.S.) $90.63
  • Beta0.86
  • Trailing P/E37.69×
  • P/E 1 year forward28.44×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.39
Updated September 2 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.79%

Based on its net profit margin of 8.79%, Hospira Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue1,1841,1751,1271,151
Total other revenue--------
Total revenue1,1841,1751,1271,151
Gross profit514524394444
Total cost of revenue670651732707
Total operating expense9651,0421,087923
Selling / general / administrative211224191224
Research & development901359986
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-63264-94
Other operating expenses, total--------
Operating income21913340228
Interest income (expense), net non-operating-15-15-18-19
Gain (loss) on sale of assets--------
Other--------
Income before tax20612222204
Income after tax1447434155
Income tax, total6248-1249
Net income1457636159
Total adjustments to net income--------
Net income before extra. items1457636159
Minority interest--------
Equity in affiliates1223
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1457636159
Inc. avail. to common incl. extra. items1457636159
Diluted net income1457636159
Dilution adjustment0--00
Diluted weighted average shares176175173172
Diluted EPS excluding extraordinary itemsvalue per share0.820.430.210.92
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.800.540.450.51